Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

JZR Gold Announces Closing Of Non-Brokered Private Placement...

July 23, 2025

Group Eleven Resources Corp. to Attend the 51st...

October 29, 2025

AI Market Update: Q2 2025 in Review

July 15, 2025

Ericsson, Rogers Launch Canada’s First Underground 5G Network...

June 21, 2025

Uranium Price Update: Q3 2025 in Review

October 16, 2025

Robinhood Shares Hit Record High on EU Launch...

July 3, 2025

New Rare Earths Venture to Target High-grade Assets...

August 21, 2025

LaFleur Minerals Inc.Ideally Positioned for Significant Explorer-to-Producer Transition

December 12, 2025

Almonty Shares Rise on Nasdaq Debut Amid US...

July 16, 2025

Placement to Institutional and Sophisticated Investors, Appointment of...

December 5, 2025